Hangsheng Zhou
Wuxi, 214122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mechanisms of tropomyosin 3 in the development of malignant tumors.
Journal: Heliyon
Published: April 30, 2024
TLN1: an oncogene associated with tumorigenesis and progression.
Journal: Discover oncology
Published: March 14, 2024
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update.
Journal: OncoTargets and therapy
Published: January 13, 2024
Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk.
Journal: Scientific reports
Published: January 02, 2024
H3K27 acetylation activated-PDLIM7 promotes castration-resistant prostate cancer progression by inducing O-Glycosylation of YAP1 protein.
Journal: Translational oncology
Published: July 19, 2023
The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors.
Journal: Current cancer drug targets
Published: May 15, 2023
The diagnostic role and mechanistic functions of exosomal lncRNAs in prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 31, 2022
Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls.
Journal: Frontiers in oncology
Published: June 29, 2022
Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.
Journal: Frontiers in oncology
Published: February 18, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026